Drug Discovery Today

DECEMBER 5, 2020

OVO Biomanufacturing, a spin-out from the University of Warwick and Coventry University, is developing digital solutions to improve the efficiency of viral vaccine and gene therapy manufacture. The technology can be applied to any virus that is grown to produce a vaccine or therapy.

Vaccine 100

Vaccine Therapies Virus Production 100

ASPET

AUGUST 3, 2023

Mechanistic modeling can be used to describe the time course of vaccine-induced humoral immunity and to identify key biological drivers in antibody production. We utilized a six-compartment mechanistic model to describe a 20-week time course of humoral immune responses in 56 non-human primates (NHPs) elicited by vaccination with Ad26.COV2.S

Vaccine 100

Vaccine Immune Response Production Drugs 100

Drug Discovery Today

JULY 7, 2022

Pfizer and Touchlight agree to patent license for Pfizer to utilise rapid, scalable, enzymatic doggybone DNA (dbDNA) in Pfizer’s clinical and commercial manufacture of its mRNA vaccines, therapeutics, and gene therapiesAgreement includes upfront payment, potential development and commercial milestone payments, and royalties upon commercializationAccess (..)

Licensing 100

Licensing Licensing Vaccine DNA 100

The Pharma Data

AUGUST 7, 2020

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, partnering up with manufacturing firm Shenzhen Kangtai Biological Products. The agreement also leaves the door open for collaboration between the two firms on the delivery of the vaccine to other global markets.

Vaccine 88

Vaccine Trials Marketing Production 88

The Pharma Data

JANUARY 29, 2021

French vaccine company Valneva said it has begun production of its investigational COVID-19 vaccine, which is now in a phase 1/2 clinical trial in the UK. Valneva also plans to test the vaccine in more than 4,000 patients in additional trials.

Vaccine 52

Vaccine Production Clinical Trials Trials 52

The Pharma Data

AUGUST 14, 2020

With the World Health Organization this week publishing a list of the latest Covid-19 candidate vaccines from around the world , Pharma IQ’s weekly round-up looks at developments from the past seven days including news on how the pharma industry plans to handle vaccine disruption and flu season.

Vaccine 52

Vaccine Production International Science 52

The Pharma Data

APRIL 14, 2021

Sanofi will invest €400 million over five years to create a unique vaccine production site in Singapore, pushing the boundaries of operations through cutting edge manufacturing and digital technologies. As a major healthcare player, it’s our responsibility to act and to meet the unprecedented growing demands for vaccines.

Vaccine 52

Vaccine Production Disease International 52

Eye on FDA

NOVEMBER 17, 2020

Coincident to COVID-19 case levels in Europe and the United States entering new and serious levels comes welcome news on the development of a vaccine. While vaccination may actually begin in December, the number of doses will be limited. In addition, the process of vaccination takes time.

Vaccine 81

Vaccine FDA Hospitals International 81

Agency IQ

MARCH 7, 2024

BY AMANDA CONTI Yesterday, FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) weighed in on strains for seasonal influenza vaccines for the Northern hemisphere 2024-2025 season. Fill out the form to read the full article.

Vaccine 59

Vaccine FDA Production 59

The Pharma Data

FEBRUARY 22, 2021

State Premier of North Rhine-Westphalia Armin Laschet and Birgitta Radermacher, President of Duesseldorf Administrative District, today visited Bayer AG’s research and production site in Wuppertal to gain an insight into the planned vaccine production there. Effective vaccines are our best weapon to combat the pandemic.

Vaccine 40

Vaccine Production Virus Pharmaceuticals 40

The Pharma Data

JANUARY 4, 2021

4, 2021 — If a second dose of the first COVID-19 vaccine is not available or the maker is not known, then another vaccine may be used, new British guidelines say, The New York Times reported Sunday. Both doses of the series should be completed with the same product.” MONDAY, Jan. The New York Times Article.

Vaccine 52

Vaccine Virus Production Science 52

The Pharma Data

FEBRUARY 18, 2022

BioNTech SE (Nasdaq: BNTX, “BioNTech”) has taken a next step to improve vaccine supply in Africa. The company has introduced its approach to establishing scalable vaccine production by developing and delivering turnkey mRNA manufacturing facilities based on a container solution.

Vaccine 40

Vaccine Production Small Molecule Therapies 40

The Pharma Data

NOVEMBER 13, 2020

WHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries. The emergency use listing, or EUL, is the first of its kind for a vaccine and paves the way for potential listing of COVID-19 vaccines.

Vaccine 52

Vaccine Virus Clinical Trials Licensing 52

The Pharma Data

DECEMBER 23, 2020

company developing UB-612 a multitope peptide-based vaccine to fight COVID-19, today announced an exclusive agreement with Aurobindo Pharma to expand its global development and commercialization of UB-612 to India and the United Nations Children’s Fund (UNICEF) agency. billion, to deliver the vaccine in multiple countries.

Vaccine 52

Vaccine Clinical Trials Trials Production 52

The Pharma Data

JUNE 24, 2021

The primary objective in the trial is to describe safety when both vaccines are co-administered, with follow up six months after vaccination. Secondary objectives are to describe immune responses produced by each of the vaccines. Secondary objectives are to describe immune responses produced by each of the vaccines.

Vaccine 52

Vaccine Immune Response FDA Licensing 52

The Pharma Data

AUGUST 14, 2020

. AstraZeneca has announced the first shipment of Flumist Quadrivalent vaccine doses have been sent to the US for the upcoming influenza season. Flumist is currently the only nasal-spray flu vaccine and is indicated for use in individuals aged two through to 49. Source link.

Vaccine 52

Vaccine Disease Production 52

The Pharma Data

DECEMBER 8, 2020

FDA Review Finds Pfizer COVID-19 Vaccine Effective After First Dose. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee suggest that Pfizer’s two-dose COVID-19 vaccine works well protecting recipients against COVID-19. Professional. TUESDAY, Dec.

Vaccine 52

Vaccine FDA Production Trials 52

The Pharma Data

APRIL 29, 2022

Food and Drug Administration is announcing its plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) in anticipation of complete submissions of emergency use authorization (EUA) requests in the coming months that have been publicly announced by COVID-19 vaccine manufacturers.

Vaccine 52

Vaccine FDA Production Regulations 52

The Pharma Data

APRIL 14, 2021

The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine. cases out of more than 6.8 million doses administered.

Vaccine 52

Vaccine Clinical Trials FDA Trials 52

The Pharma Data

MARCH 21, 2022

Food and Drug Administration is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., Timing and populations for COVID-19 vaccine booster doses in the coming months. Along with the independent experts of the advisory committee, representatives from the U.S.

Vaccine 52

Vaccine FDA Virus Production 52

The Pharma Data

DECEMBER 17, 2020

Advisory Committee Votes to Recommend EUA for Moderna Vaccine. 17, 2020 — The Moderna COVID-19 vaccine received recommendation from a U.S. Food and Drug Administration advisory committee on Thursday, clearing the way for it to become the second COVID-19 vaccine to be granted emergency use authorization. THURSDAY, Dec.

Vaccine 52

Vaccine Government Clinical Trials FDA 52

PPD

JUNE 13, 2023

Clinical trials for COVID-19 vaccines changed how all vaccine trials are conducted. The success of the COVID-19 vaccines has brought renewed interest to vaccine development across indications and therapeutic areas. This increase in activity means the vaccine space will be fiercely competitive in the coming years.

Vaccine 52

Vaccine Clinical Trials Clinical Research Trials 52

The Pharma Data

NOVEMBER 20, 2020

Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. BNT162b2 (SARS-CoV-2 vaccine) FDA Approval History. Source: FDA.

Vaccine 52

Vaccine FDA FDA Approval Production 52

The Pharma Data

JUNE 24, 2021

This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine in this age group. COMIRNATY was the first COVID-19 vaccine to receive authorization in the EU and is the first to have its CMA extended to adolescents. Participants received two 30

Vaccine 52

Vaccine Clinical Trials Trials FDA 52

The Pharma Data

MARCH 5, 2021

Novartis announced today that it has signed an initial agreement to manufacture the mRNA and bulk drug product for the COVID-19 vaccine candidate CVnCoV from CureVac to aid in the fight against the COVID-19 pandemic. Preparations for the start of production, technology transfer and test runs are already underway.

Vaccine 52

Vaccine Production Biosimilars Hospitals 52

The Pharma Data

DECEMBER 9, 2020

COVID-19 Vaccine Caution Issued by U.K. 9, 2020 — People with a “significant history” of allergic reactions should not receive the new Pfizer-BioNTech COVID-19 vaccine, U.K. mass vaccination program, the Associated Press reported. mass vaccination program, the Associated Press reported. Professional.

Vaccine 52

Vaccine Clinical Trials Regulations Trials 52

The Pharma Data

JANUARY 12, 2021

Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the COVID-19 Moderna Vaccine in Switzerland. million doses of the COVID-19 Vaccine Moderna. About the COVID-19 Vaccine Moderna.

Vaccine 52

Vaccine RNA Clinical Trials Science 52

The Pharma Data

MAY 5, 2022

The Fact Sheet for Healthcare Providers Administering Vaccine now reflects the revision of the authorized use of the Janssen COVID-19 Vaccine and includes a warning statement at the beginning of the fact sheet for prominence which summarizes information on the risk for TTS.

Vaccine 52

Vaccine FDA Pharmaceutical Companies Production 52

EG Life Sciences

JUNE 2, 2022

At the most recent Bio-IT World conference , Barnhart shows how Agile practices not only bring products to market faster – they also save lives.

Vaccine 52

Vaccine Pharmaceuticals Marketing Production 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic.

Vaccine 52

Vaccine Immune Response Government RNA 52

The Pharma Data

JANUARY 6, 2021

(Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Commission has granted a conditional marketing authorization (CMA) for COVID-19 Vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled out across the European Union.

Vaccine 52

Vaccine RNA FDA Clinical Trials 52

The Pharma Data

DECEMBER 19, 2020

government’s public-private partnership to deliver COVID-19 vaccines to Americans, and under the direction of the Centers for Disease Control and Prevention (CDC) , McKesson began distributing Moderna’s COVID-19 vaccines and the ancillary supply kits needed to administer them. as well as handling the distribution of vaccines.

Government 52

Government Vaccine Pharmacy Pharmaceuticals 52

The Pharma Data

DECEMBER 3, 2020

The Pfizer – BioNTech and Moderna ’s COVID-19 vaccines are currently being reviewed for possible Emergency Use Authorization (EUA) by the U.S. On Tuesday, the Pfizer-BioNTech vaccine was granted temporary authorization in the UK and dosing will begin next week. Pfizer gets its raw materials for the vaccine from the U.S.

Vaccine 52

Vaccine Government RNA FDA 52

The Pharma Data

NOVEMBER 25, 2020

COVID-19 Vaccine Distribution Could Begin in Mid-December. 25, 2020 — The Pfizer COVID-19 vaccine could start being distributed in the United States “soon after” a U.S. 10 to consider the company’s application for emergency use authorization (EUA) of the vaccine, according to U.S. Professional.

Vaccine 52

Vaccine FDA Science Production 52

The Pharma Data

MAY 5, 2022

In animal studies that mimic human exposures, an investigational COVID vaccine designed to be taken orally not only protects the host, but also decreases the airborne spread of the virus to other close contacts. The human vaccine is designed to be taken as a pill. The study, led by Duke researcher Stephanie N. Langel, Ph.D.,

Vaccine 52

Vaccine Disease Virus Science 52

The Pharma Data

AUGUST 4, 2020

The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the mass immunisation of the populace in October. However, Russia’s vaccine is still largely surrounding in mystery. However, Russia’s vaccine is still largely surrounding in mystery.

Vaccine 52

Vaccine Clinical Trials Trials Government 52

The Pharma Data

OCTOBER 20, 2020

No COVID-19 Vaccines Allowed in California Without State Approval. 20, 2020 — California is not going to allow the use of any COVID-19 vaccines until its own panel of experts approves them, Gov. The governor named 11 doctors and scientists who will review any vaccines approved by the federal government or vaccine developers.

Vaccine 52

Vaccine Doctors Government Disease 52